Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

663 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of Erythropoietin-Stimulating Agents on Blood Pressure in Patients with Non-Dialysis CKD and Renal Anemia.
Ohki K, Wakui H, Uneda K, Azushima K, Haruhara K, Kinguchi S, Urate S, Yamada T, Yamaji T, Kobayashi R, Kanaoka T, Minegishi S, Ishigami T, Fujikawa T, Toya Y, Tamura K. Ohki K, et al. Among authors: fujikawa t. Kidney Dis (Basel). 2020 Jul;6(4):299-308. doi: 10.1159/000507396. Epub 2020 Jun 12. Kidney Dis (Basel). 2020. PMID: 32903814 Free PMC article.
Effects of multiple factorial intervention on ambulatory BP profile and renal function in hypertensive type 2 diabetic patients with overt nephropathy - a pilot study.
Kanaoka T, Tamura K, Moriya T, Tanaka K, Konno Y, Kondoh S, Toyoda M, Umezono T, Fujikawa T, Ohsawa M, Dejima T, Maeda A, Wakui H, Haku S, Yanagi M, Mitsuhashi H, Ozawa M, Okano Y, Ogawa N, Yamakawa T, Mizushima S, Suzuki D, Umemura S. Kanaoka T, et al. Among authors: fujikawa t. Clin Exp Hypertens. 2011;33(4):255-63. doi: 10.3109/10641963.2011.583971. Clin Exp Hypertens. 2011. PMID: 21699452 Free article.
Combination therapy of angiotensin II receptor blocker and calcium channel blocker exerts pleiotropic therapeutic effects in addition to blood pressure lowering: amlodipine and candesartan trial in Yokohama (ACTY).
Maeda A, Tamura K, Kanaoka T, Ohsawa M, Haku S, Azushima K, Dejima T, Wakui H, Yanagi M, Okano Y, Fujikawa T, Toya Y, Mizushima S, Tochikubo O, Umemura S. Maeda A, et al. Among authors: fujikawa t. Clin Exp Hypertens. 2012;34(4):249-57. doi: 10.3109/10641963.2012.681081. Epub 2012 May 9. Clin Exp Hypertens. 2012. PMID: 22571446 Free article. Clinical Trial.
Relationship of ambulatory blood pressure and the heart rate profile with renal function parameters in hypertensive patients with chronic kidney disease.
Kanaoka T, Tamura K, Ohsawa M, Yanagi M, Haku S, Wakui H, Maeda A, Dejima T, Azushima K, Mitsuhashi H, Okano Y, Fujikawa T, Toya Y, Mizushima S, Tochikubo O, Umemura S. Kanaoka T, et al. Among authors: fujikawa t. Clin Exp Hypertens. 2012;34(4):264-9. doi: 10.3109/10641963.2012.681082. Epub 2012 May 11. Clin Exp Hypertens. 2012. PMID: 22578052 Free article.
Effects of aliskiren-based therapy on ambulatory blood pressure profile, central hemodynamics, and arterial stiffness in nondiabetic mild to moderate hypertensive patients.
Kanaoka T, Tamura K, Ohsawa M, Wakui H, Maeda A, Dejima T, Azushima K, Haku S, Mitsuhashi H, Yanagi M, Oshikawa J, Uneda K, Aoki K, Fujikawa T, Toya Y, Uchino K, Umemura S. Kanaoka T, et al. Among authors: fujikawa t. J Clin Hypertens (Greenwich). 2012 Aug;14(8):522-9. doi: 10.1111/j.1751-7176.2012.00640.x. Epub 2012 May 3. J Clin Hypertens (Greenwich). 2012. PMID: 22863160 Free PMC article. Clinical Trial.
Addition of aliskiren to Angiotensin receptor blocker improves ambulatory blood pressure profile and cardiorenal function better than addition of benazepril in chronic kidney disease.
Ohsawa M, Tamura K, Kanaoka T, Wakui H, Maeda A, Dejima T, Azushima K, Uneda K, Kobayashi R, Tsurumi-Ikeya Y, Toya Y, Fujikawa T, Umemura S. Ohsawa M, et al. Among authors: fujikawa t. Int J Mol Sci. 2013 Jul 24;14(8):15361-75. doi: 10.3390/ijms140815361. Int J Mol Sci. 2013. PMID: 23887656 Free PMC article. Clinical Trial.
L/N-type calcium channel blocker cilnidipine added to renin-angiotensin inhibition improves ambulatory blood pressure profile and suppresses cardiac hypertrophy in hypertension with chronic kidney disease.
Kanaoka T, Tamura K, Wakui H, Ohsawa M, Azushima K, Uneda K, Kobayashi R, Fujikawa T, Tsurumi-Ikeya Y, Maeda A, Yanagi M, Toya Y, Umemura S. Kanaoka T, et al. Among authors: fujikawa t. Int J Mol Sci. 2013 Aug 16;14(8):16866-81. doi: 10.3390/ijms140816866. Int J Mol Sci. 2013. PMID: 23959116 Free PMC article. Clinical Trial.
Bofu-tsu-shosan, an oriental herbal medicine, exerts a combinatorial favorable metabolic modulation including antihypertensive effect on a mouse model of human metabolic disorders with visceral obesity.
Azushima K, Tamura K, Wakui H, Maeda A, Ohsawa M, Uneda K, Kobayashi R, Kanaoka T, Dejima T, Fujikawa T, Yamashita A, Toya Y, Umemura S. Azushima K, et al. Among authors: fujikawa t. PLoS One. 2013 Oct 9;8(10):e75560. doi: 10.1371/journal.pone.0075560. eCollection 2013. PLoS One. 2013. PMID: 24130717 Free PMC article.
663 results